Sequent Scientific [SEQUENT] vs Aarti Drugs [AARTIDRUGS] Detailed Stock Comparison

Sequent Scientific

NSE
Loading...

Aarti Drugs

NSE
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Sequent Scientific wins in 2 metrics, Aarti Drugs wins in 17 metrics, with 0 ties. Aarti Drugs appears stronger overall.

View Metrics Details

Vital Metrics Comparison

MetricSequent ScientificAarti DrugsBetter
P/E Ratio (TTM)166.3323.66Aarti Drugs
Price-to-Book Ratio6.613.26Aarti Drugs
Debt-to-Equity Ratio62.4744.92Aarti Drugs
PEG Ratio1.400.37Aarti Drugs
EV/EBITDA30.6317.07Aarti Drugs
Profit Margin (TTM)1.85%7.80%Aarti Drugs
Operating Margin (TTM)7.56%10.11%Aarti Drugs
EBITDA Margin (TTM)7.56%10.11%Aarti Drugs
Return on Equity2.84%12.28%Aarti Drugs
Return on Assets (TTM)1.37%6.53%Aarti Drugs
Free Cash Flow (TTM)$442.73M$674.22MAarti Drugs
Dividend YieldN/A0.22%N/A
1-Year Return-10.14%-5.48%Aarti Drugs
Price-to-Sales Ratio (TTM)3.001.84Aarti Drugs
Enterprise Value$50.87B$50.47BSequent Scientific
EV/Revenue Ratio3.172.08Aarti Drugs
Gross Profit Margin (TTM)46.86%36.77%Sequent Scientific
Revenue per Share (TTM)$64$265Aarti Drugs
Earnings per Share (Diluted)$1.12$20.63Aarti Drugs
Beta (Stock Volatility)0.910.12Aarti Drugs
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends

Sequent Scientific vs Aarti Drugs Stock Performance Analysis

Loading Price Chart...

Sequent Scientific
Aarti Drugs
Sequent Scientific Stock Overview | Aarti Drugs Stock Overview

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Sequent Scientific1.15%-8.42%9.29%-3.35%37.17%0.89%
Aarti Drugs0.73%-5.64%3.08%3.92%42.25%7.15%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Sequent Scientific-10.14%69.59%19.72%26.36%26.36%26.36%
Aarti Drugs-5.48%-1.60%-50.42%217.00%2,669.86%2,850.73%

News Based Sentiment: Sequent Scientific vs Aarti Drugs

Sequent Scientific

News based Sentiment: POSITIVE

Sequent Scientific's impressive Q1 FY2025-26 results, with a 21.9% revenue increase and a massive 1283.5% profit jump, clearly demonstrate a positive shift in the company's financial performance. This strong showing is a significant development for investors, indicating potential for future growth and returns.

View Sequent Scientific News Sentiment Analysis

Aarti Drugs

News based Sentiment: POSITIVE

Aarti Drugs reported substantial profit growth in both Q1FY26 and FY2025, coupled with increased institutional interest from Mutual Funds. While shareholding changes and recent price volatility exist, the overall narrative points towards a strengthening investment case.

View Aarti Drugs News Sentiment Analysis

Performance & Financial Health Analysis: Sequent Scientific vs Aarti Drugs

MetricSEQUENTAARTIDRUGS
Market Information
Market Cap i₹48.13B₹44.55B
Market Cap CategorySmall capSmall cap
10 Day Avg. Volume i1,494,055201,942
90 Day Avg. Volume i754,164187,563
Last Close₹186.29₹491.60
52 Week Range₹117.35 - ₹240.70₹312.00 - ₹564.05
% from 52W High-22.60%-12.84%
All-Time High₹336.50 (Jun 28, 2021)₹1,026.95 (Oct 05, 2020)
% from All-Time High-44.64%-52.13%
Growth Metrics
Quarterly Revenue Growth0.13%0.06%
Quarterly Earnings Growth1.20%0.62%
Financial Health
Profit Margin (TTM) i0.02%0.08%
Operating Margin (TTM) i0.08%0.10%
Return on Equity (TTM) i0.03%0.12%
Debt to Equity (MRQ) i62.4744.92
Cash & Liquidity
Book Value per Share (MRQ)₹28.19₹149.84
Cash per Share (MRQ)₹2.52₹2.48
Operating Cash Flow (TTM) i₹360.47M₹2.83B
Levered Free Cash Flow (TTM) i₹218.78M₹1.68B
Dividends
Last 12-Month Dividend Yield iN/A0.22%
Last 12-Month Dividend i₹0.00₹1.00

Valuation & Enterprise Metrics Analysis: Sequent Scientific vs Aarti Drugs

MetricSEQUENTAARTIDRUGS
Price Ratios
P/E Ratio (TTM) i166.3323.66
Forward P/E i36.8915.02
PEG Ratio i1.400.37
Price to Sales (TTM) i3.001.84
Price to Book (MRQ) i6.613.26
Market Capitalization
Market Capitalization i₹48.13B₹44.55B
Enterprise Value i₹50.87B₹50.47B
Enterprise Value Metrics
Enterprise to Revenue i3.172.08
Enterprise to EBITDA i30.6317.07
Risk & Other Metrics
Beta i0.910.12
Book Value per Share (MRQ) i₹28.19₹149.84

Financial Statements Comparison: Sequent Scientific vs Aarti Drugs

Financial Metrics

Loading Financial Charts...

Revenue

EBITDA

Shareholders Equity

Operating Margin

Free Cash Flow

Long Term Debt

Profit Margin

Current Ratio

Operating Cash Flow

Income Statement (MRQ)

Metric (MRQ)SEQUENTAARTIDRUGS
Revenue/Sales i₹4.41B₹5.91B
Cost of Goods Sold i₹2.35B₹3.73B
Gross Profit i₹2.07B₹2.17B
Research & Development iN/AN/A
Operating Income (EBIT) i₹333.50M₹593.60M
EBITDA i₹505.30M₹743.90M
Pre-Tax Income i₹255.20M₹511.10M
Income Tax i₹79.50M₹-28.60M
Net Income (Profit) i₹175.70M₹539.70M

Balance Sheet & Liquidity Metrics (MRQ)

Metric (MRQ)SEQUENTAARTIDRUGS
Cash & Equivalents i₹626.60M₹45.77M
Total Current Assets i₹8.74B₹13.38B
Total Current Liabilities i₹5.05B₹8.37B
Long-Term Debt i₹3.00B₹2.86B
Total Shareholders Equity i₹7.70B₹13.69B
Retained Earnings i₹1.25B₹12.40B
Property, Plant & Equipment i₹2.84B₹27.03M

Cash Flow Statement Comparison (MRQ)

Metric (MRQ)SEQUENTAARTIDRUGS
Operating Cash Flow iN/AN/A
Capital Expenditures iN/AN/A
Free Cash Flow iN/AN/A
Debt Repayment iN/AN/A
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricSEQUENTAARTIDRUGS
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Average Daily Volume (10 Day) i1,494,055201,942
Average Daily Volume (90 Day) i754,164187,563
Shares Outstanding i249.89M91.27M
Float Shares i118.88M39.04M
% Held by Insiders i0.52%0.60%
% Held by Institutions i0.13%0.11%

Dividend Analysis & Yield Comparison: Sequent Scientific vs Aarti Drugs

MetricSEQUENTAARTIDRUGS
Last 12-Month Dividend i₹0.00₹1.00
Last 12-Month Dividend Yield iN/A0.22%
3-Year Avg Annual Dividend i₹0.00₹1.00
3-Year Avg Dividend Yield iN/A0.23%
3-Year Total Dividends i₹0.00₹3.00
Ex-Dividend DateN/AFeb 04, 2025